Joseph O. Moore

4.0k total citations
17 papers, 1.3k citations indexed

About

Joseph O. Moore is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Joseph O. Moore has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 8 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Joseph O. Moore's work include Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Joseph O. Moore is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Joseph O. Moore collaborates with scholars based in United States, Italy and United Kingdom. Joseph O. Moore's co-authors include Richard A. Larson, Clara D. Bloomfield, Bayard L. Powell, Jonathan E. Kolitz, Andrew J. Carroll, Krzysztof Mrózek, Amy S. Ruppert, James W. Vardiman, Guido Marcucci and Michael A. Caligiuri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

Joseph O. Moore

17 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph O. Moore United States 10 1.0k 555 368 350 181 17 1.3k
Kiyotaka Kashima Japan 8 992 1.0× 499 0.9× 386 1.0× 274 0.8× 132 0.7× 14 1.2k
S Chatters United Kingdom 6 1.3k 1.3× 521 0.9× 382 1.0× 416 1.2× 154 0.9× 8 1.4k
Phoenix A. Ho United States 15 876 0.8× 550 1.0× 149 0.4× 351 1.0× 259 1.4× 29 1.2k
Fen‐Yu Lee Taiwan 14 918 0.9× 578 1.0× 432 1.2× 174 0.5× 155 0.9× 20 1.2k
Tamara Weiss Germany 9 945 0.9× 462 0.8× 456 1.2× 305 0.9× 81 0.4× 22 1.1k
Hans Beier Ommen Denmark 17 940 0.9× 544 1.0× 195 0.5× 430 1.2× 117 0.6× 44 1.1k
Nathalie Grardel France 15 848 0.8× 322 0.6× 591 1.6× 281 0.8× 160 0.9× 40 1.3k
Iris H.I.M. Hollink Netherlands 19 848 0.8× 684 1.2× 144 0.4× 313 0.9× 109 0.6× 35 1.2k
SC Raimondi United States 15 874 0.8× 454 0.8× 171 0.5× 733 2.1× 147 0.8× 15 1.3k
Olga Salamero Spain 13 625 0.6× 381 0.7× 282 0.8× 180 0.5× 167 0.9× 46 890

Countries citing papers authored by Joseph O. Moore

Since Specialization
Citations

This map shows the geographic impact of Joseph O. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph O. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph O. Moore more than expected).

Fields of papers citing papers by Joseph O. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph O. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph O. Moore. The network helps show where Joseph O. Moore may publish in the future.

Co-authorship network of co-authors of Joseph O. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph O. Moore. A scholar is included among the top collaborators of Joseph O. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph O. Moore. Joseph O. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Spaiser, Viktoria, et al.. (2024). The effects of communicating climate change threat: mobilizing anger and authoritarian affect displacement. Environmental Sociology. 10(4). 408–419. 2 indexed citations
2.
Winn, Aaron N., Ehab Atallah, Jörge E. Cortes, et al.. (2023). Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia. JAMA Network Open. 6(12). e2347950–e2347950. 4 indexed citations
3.
Malone, Laurie A., et al.. (2023). Usability of the GAIMplank Video Game Controller for People With Mobility Impairments: Observational Study. JMIR Serious Games. 11. e38484–e38484. 5 indexed citations
4.
Flynn, Kathryn E., Kevin P. Weinfurt, Lin Li, et al.. (2019). Patient-Reported Outcome Results from the U.S. Life after Stopping TKIs (LAST) Study in Patients with Chronic Myeloid Leukemia. Blood. 134(Supplement_1). 705–705. 3 indexed citations
5.
DiLillo, David J., J. Brice Weinberg, Ayumi Yoshizaki, et al.. (2012). Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia. 27(1). 170–182. 135 indexed citations
6.
7.
8.
Baer, Maria R., Stephen L. George, Michael A. Caligiuri, et al.. (2008). Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720. Journal of Clinical Oncology. 26(30). 4934–4939. 94 indexed citations
9.
10.
Marcucci, Guido, Claudia D. Baldus, Michael D. Radmacher, et al.. (2005). Overexpression of the ERG Gene Is an Adverse Prognostic Factor in Acute Myeloid Leukemia (AML) with Normal Cytogenetics (NC): A Cancer and Leukemia Group B Study (CALGB).. Blood. 106(11). 335–335. 2 indexed citations
11.
Marcucci, Guido, Krzysztof Mrózek, Amy S. Ruppert, et al.. (2005). Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study. Journal of Clinical Oncology. 23(24). 5705–5717. 265 indexed citations
12.
Marcucci, Guido, Claudia D. Baldus, Amy S. Ruppert, et al.. (2005). Overexpression of the ETS-Related Gene, ERG, Predicts a Worse Outcome in Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study. Journal of Clinical Oncology. 23(36). 9234–9242. 160 indexed citations
13.
Byrd, John C., Amy S. Ruppert, Krzysztof Mrózek, et al.. (2004). Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461. Journal of Clinical Oncology. 22(6). 1087–1094. 156 indexed citations
14.
15.
Farag, Sherif S., Amy S. Ruppert, Krzysztof Mrózek, et al.. (2004). Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study. Journal of Clinical Oncology. 23(3). 482–493. 99 indexed citations
16.
17.
Baldus, Claudia D., Stephan M. Tanner, Amy S. Ruppert, et al.. (2003). BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. Blood. 102(5). 1613–1618. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyotaka Kashima Breakdown of academic impact, for papers by S Chatters Breakdown of academic impact, for papers by Phoenix A. Ho Breakdown of academic impact, for papers by Fen‐Yu Lee Breakdown of academic impact, for papers by Tamara Weiss Breakdown of academic impact, for papers by Hans Beier Ommen Breakdown of academic impact, for papers by Nathalie Grardel Breakdown of academic impact, for papers by Iris H.I.M. Hollink Breakdown of academic impact, for papers by SC Raimondi Breakdown of academic impact, for papers by Olga Salamero
Rankless by CCL
2026